Cytek Biosciences Inc logo

Cytek Biosciences Inc (CTKB)

$5.52

Cytek Biosciences Inc (CTKB) Share Price Forecast
Currently 10 wall-street analysts regularly analyze the financials of Cytek Biosciences Inc on a frequent basis to provide recommendations along with target share price. 10 analysts offering 12-month price forecasts for Cytek Biosciences Inc (CTKB) have a share price target of $14. This median of share price forecast represents a 153.62% upside from the latest price of $5.52 as on 01.10.23.

Cytek Biosciences Inc (CTKB) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Cytek Biosciences Inc (CTKB) share price will touch around $14 in next 12-months.
Cytek Biosciences Inc (CTKB) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Cytek Biosciences Inc's share price and its median forecast price. As on 01.10.23, the difference is -44.79%

Cytek Biosciences Inc (CTKB): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Cytek Biosciences Inc (CTKB) Share Price : Analyst Recommendation
Based on 10 analysts tracking and researching Cytek Biosciences Inc (CTKB) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
6
6
6
Outperform
2
2
2
Hold
2
2
2
Underperform
0
0
0
Sell
0
0
0
Cytek Biosciences Inc (CTKB) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Cytek Biosciences Inc (CTKB) is $14, offered by 10 analysts offering 12-month price forecasts.

Cytek Biosciences Inc (CTKB) has a maximum of 1.54 upside potential, based on 10 analysts offering 12-month price forecasts.

Based on 10 analysts tracking and researching Cytek Biosciences Inc (CTKB), 80% have a buy recommendation. Remaining 20% have either sell or hold recommendations.

The latest share price of Cytek Biosciences Inc (CTKB) is $5.52 as of 01/10/2023.

8 of total 10 analysts offering stock ratings for Cytek Biosciences Inc CTKB have recommended buy rating.